7 Hills Pharma Receives MM SBIR Grant from NIAID to Accelerate Novel Vaccine Combination Against Chagas Disease
7 Hills Pharma HOUSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC ('7 Hills' or '7HP'), a clinical-stage pharma company developing a pla...
7 Hills Pharma HOUSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC ('7 Hills' or '7HP'), a clinical-stage pharma company developing a platform of first-in-class oral small molecules to enhance the effectiveness of a wide range of immunotherapies, was awarded a 3-year grant worth almost $3 million from the National Institute of Allergy and Infectious Diseases to progress its work with collaborator Dr. Nisha Garg from the University of Texas Medical Branch (UTMB) toward the creation of the first vaccine against Chagas disease.